Abstract
Tuberculosis (TB) is the second leading infectious cause of mortality worldwide and arguably the most important neglected topic in bioethics. This chapter: (1) explains the ethical importance of TB, (2) documents its neglect in bioethics discourse, (3) maps the terrain of ethical issues associated with TB, and (4) advocates a moderate pluralistic approach to ethical issues associated with TB.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
A recent exception was the workshop organized by Anne Fogot-Largeault—with participation of Mary Edginton, Lourdes Garcia-Garcia, and Brigitte Gicquel—on “TB Ethics” at the 8th World Congress of the International Association Bioethics (2006) in Beijing. We also admit that the New York epidemic of the 1980s and 1990s received some important coverage.
References
Anand, S., F. Peter, and A. Sen, eds. 2004. Public Health, Ethics, and Equity. New York: Oxford University Press.
Balint, J., S. Philpott, R. Baker, and M. Strosberg, eds. 2006. Ethics and Epidemics. Amsterdam: JAI.
Bates, I., Fenton, C., Gruber, J., Lalloo, D., Medina Lara, A., Squire, S.B., Theobald, S., Thomson, R., and Tolhurst, R. 2004. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infectious Diseases 4 (5): 267–277.
Bayer, R., and L. Dupuis. 1995. Tuberculosis, public health, and civil liberties. Annual Review of Public Health 16: 307–326.
Beauchamp, D.E., and B.S. Steinbock, eds. 1999. New Ethics for the Public’s Health. New York: Oxford University Press.
Boseley, S. 2006. Global alert over deadly new TB strains. Guardian. Available at: http://www.guardian.co.uk/print/0,329569751-110418,00.html (Accessed 15 May 2007).
Boylan, M., ed. 2004. Public Health Policy and Ethics. Dordrecht: Kluwer.
CDC. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004. Morbidity and Mortality Weekly Report 55 (11): 301–305.
Cobelens, F.G. 2007. Tuberculosis risks for health care workers in Africa. Clinical Infectious Diseases 44: 324–326. Available at: http://www.journals.uchicago.edu/CID/journal/issues/v44n3/41151/41151.text.html-fn1#fn1.
Cohen, J.C., and P. Illingworth. 2003. The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements. Developing World Bioethics 3 (1): 27–48.
Cohen, J.C., P. Illingworth, and U. Schüklenk, eds. 2006. The Power of Pills: Social, Ethical, and Legal Issues in Drug Development, Marketing and Pricing. London: Pluto.
Coker, R. 2000. Tuberculosis, non-compliance and detention for the public health. Journal of Medical Ethics 26: 157–159.
Coker, R. 2003. Asylum and Migration Working Paper 1: Migration, Public Health and Compulsory Screening for TB and HIV. London: Institute for Public Policy Research.
Coughlin, S.S., C.L. Soskolne, and K.W. Goodman, eds. 1998. Case Studies in Public Health Ethics. Washington, DC: American Public Health Association.
Dawson, A., and M. Verweij, eds. 2007. Ethics, Prevention, and Public Health. Oxford: Oxford University Press.
Democracy Now. 2007. Is sickness a crime? Arizona man with TB locked up indefinitely in solitary confinement. Available at: http://www.democracynow.org/article.pl?sid=07/04/06/142246 (Accessed 10 May 2007).
Dye, C., M. Hosseini, and C. Watt. 2007. Did we reach the 2005 targets for tuberculosis control. Bulletin of the World Health Organization 85: 364–369.
Farmer, P. 1999. Infections and Inequalities: The Modern Plagues. Berkeley, CA: University of California Press.
Farmer, P. 2003. Pathologies of Power: Health, Human Rights, and the New War on the Poor. Berkeley, CA: University of California Press.
Floyd, K. 2007. Global progress towards the TB control targets (with a special attention to TB/ HIV and MDR-TB). In Presentation at the Stop TB Symposium, 38th World Conference on Lung Health, 8 November, Cape Town, South Africa.
Francis, L.P., M.P. Battin, J.A. Jacobson, C.B. Smith, and J. Botkin. 2005. How infectious disease got left out—and what this omission might have meant for bioethics. Bioethics 19 (4): 207–322.
Francis, L.P., Battin, M.P., Botkin, J., Jacobson, J., and Smith, C. 2006. Infectious disease and the ethics of research: the moral significance of communicability. In Ethics in Biomedical Research: International Perspectives, ed. by Hayry, M., Takala, T., and Herissone-Kelly, P. New York: Rodopi.
Gandy, M., and A. Zumla. 2002. The resurgence of disease: Social and historical perspectives on the ‘new’ tuberculosis. Social Science and Medicine 55: 385–396.
Garrett, L. 2007. The challenge of global health. Foreign Affairs, January/February 2007. Available at: http://www.foreignaffairs.org/20070101faessay86103/laurie-garrett/thechallenge-of-global-health.html?mode=print (Accessed 20 February 2007).
Gostin, L.O., ed. 2002. Public Health Law and Ethics. Berkeley, CA: University of California Press.
Harries, A., and C. Dye. 2006. Tuberculosis. Annals of Tropical Medicine and Parasitology 100 (5–6): 415–431.
Harris, J., and S. Holm. 1995. Is there a duty not to infect others? British Medical Journal 311: 1215–1217.
Jackson, S., A.C. Sleigh, G.J. Wang, and X.L. Liu. 2006. Poverty and the economic effects of TB in rural China. International Journal of Tuberculosis and Lung Disease 10 (10): 1104–1110.
Kremer, M., and R. Glennerster. 2004. Strong Medicine. Princeton, NJ: Princeton University Press.
Lienhardt, C., Ogden, J., and Sow, S. 2003. Rethinking the social context of illness: interdisciplinary approaches to tuberculosis control. In The Return of the White Plague: Global Poverty and the ‘New’ Tuberculosis, ed. by Gandy, M., and Zumla, A. London: Verso.
Lurie, P., and S. Wolfe. 1997. Unethical trials of interventions to reduce perinatal transmission of the Human Immunodeficiency Virus in developing countries. The New England Journal of Medicine 337: 853–856.
Ly, T., M.J. Selgelid, and I. Kerridge. 2007. Pandemic and public health controls: Toward an equitable compensation system. Journal of Law and Medicine 15 (2): 296–302.
MacIntyre, C.R., A.J. Plant, A. Yung, and J.A. Streeton. 1997. Missed opportunities for prevention of tuberculosis in Victoria, Australia. International Journal of Tuberculosis and Lung Disease 1 (2): 135–141.
Maloney, S. 2004. National migration health policies: shifting the paradigm from exclusion to inclusion. In: IOM’s International Dialogue on Migration, Seminar on Health and Migration, Geneva, 9–11 June 2004. Available at: http://www.iom.int/en/know/idm/smh_200406.shtml (Accessed 11 May 2007).
Moran, M., A.L. Ropars, J. Guzman, J. Diaz, and C. Garrison. 2005. The New Landscape of Neglected Disease Drug Development. London: The Wellcome Trust.
MSF, Extensive drug resistant tuberculosis (XDR-TB). 2006. Available at: http://www.accessmedmsf.org/prod/publications.asp?scntid=271020061722542&contenttype=PARA (Accessed 12 February 2007).
MSF. 2007. No time to wait. Available at: http://doctorswithoutborders.org/news/tuberculosis/tb_statement.cfm (Accessed 10 February 2007).
Pogge, T. 2005. Human rights and global health: A research program. Metaphilosophy 36 (1/2): 182–209.
Price-Smith, A.T. 2001. The Health of Nations: Infectious Disease, Environmental Change, and Their Effects on National Security and Development. Cambridge, MA: MIT Press.
Reid, L. 2005. Diminishing returns? Risk and the duty to care in the SARS epidemic. Bioethics 19 (4): 348–361.
Resnik, D.A. 2004. The distribution of biomedical research resources and international justice. Developing World Bioethics 4 (1): 42–57.
Sakoane, R. 2007. XDR-TB in South Africa: Back to TB sanatoria perhaps? PLoS Medicine 4 (4): e160.
Schüklenk, U., and R.E. Ashcroft. 2002. Affordable access to essential medication in developing countries: Conflicts between ethical and economic imperatives. Journal of Medicine and Philosophy 27 (2): 179–195.
Selgelid, M.J. 2005. Ethics and infectious disease. Bioethics 19 (3): 272–289.
Selgelid, M.J. OnlineEarly. 2007. Improving global health: counting reasons why. Developing World Bioethics. Forthcoming in print, https://doi.org/10.1111/j.1471-8847.2007.00185.x.
Selgelid, M.J., M.P. Battin, and C.B. Smith, eds. 2006. Ethics and Infectious Disease. Oxford: Blackwell.
Singh, J.A., Upshur, R., and Padayatchi, N. 2007. XDR-TB in South Africa: no time for denial or complacency. PLoS Medicine 4 (1): e50. 101371/journal.pmed.0040050
Singh, V., A. Jaiswal, J.D.H. Porter, J.A. Ogden, R. Sarin, P.P. Sharma, V.K. Arora, and R.C. Jain. 2002. TB control, poverty, and vulnerability in Delhi, India. Tropical Medicine and International Health 7: 693–700.
Smith, C.B., M.P. Battin, J.A. Jacobson, L.P. Francis, J.R. Botkin, E.P. Asplund, G.J. Domek, and B. Hawkins. 2004. Are there characteristics of infectious disease that raise special ethical issues? Developing World Bioethics 4 (1): 1–16.
Sterckx, S. 2004. Patents and access to drugs in developing countries: An ethical analysis. Developing World Bioethics 4 (1): 58–75.
Tausig, M., M.J. Selgelid, S. Subedi, and J. Subedi. 2006. Taking sociology seriously: A new approach to the bioethical problems of infectious disease. Sociology of Health and Illness 28 (6): 839–849.
UNAIDS. 2007. AIDS Epidemic Update: December 2007. Available at: www.unaids.org (Accessed 4 March 2008).
University of Toronto Joint Centre for Bioethics, Pandemic Influenza Working Group. 2005. Stand on guard for thee: ethical considerations in preparedness planning for pandemic influenza. Available at: http://www.utoronto.ca/jcb/home/documents/pandemic.pdf (Accessed 15 May 2007).
Verweij, M. 2005. Obligatory precautions against infection. Bioethics 19 (4): 323–335.
WHO. 2006a. Weekly epidemiological record, September 2006a. Available at: http://www.who.int/wer (Accessed 10 February 2007).
WHO. 2006b. The Stop TB Strategy. Geneva: World Health Organization.
WHO. 2007a. Fact sheet no. 104: tuberculosis (revised March 2007a). Available at: http://www.who.int/mediacentre/factsheets/fs104/en/index.html (Accessed 8 December 2008).
WHO. 2007b. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. Geneva, World Health Organization. WHO/HTM/TB/2007b.376.
Acknowledgements
We thank the Brocher Foundation in Hermance, and the Institute for Biomedical Ethics at the University of Geneva, in Switzerland, for hosting the lead author as a visiting researcher during the period this chapter was written.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Selgelid, M.J., Kelly, P.M., Sleigh, A. (2023). TB Matters More. In: Boylan, M. (eds) International Public Health Policy and Ethics. The International Library of Bioethics, vol 106. Springer, Cham. https://doi.org/10.1007/978-3-031-39973-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-031-39973-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-39972-5
Online ISBN: 978-3-031-39973-2
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)